Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4046/trd.2015.78.3.168 http://scihub22266oqcxt.onion/10.4046/trd.2015.78.3.168 C4499582!4499582!26175768     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26175768.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Tuberc+Respir+Dis+(Seoul) 2015 ; 78 (3): 168-74 Nephropedia Template TP {{tp|p=26175768|t=2015. Medical Management of Drug-Resistant Tuberculosis |pdf=|usr=}}{{26175768}} gab.com Text Medical Management of Drug-Resistant Tuberculosis JO: Tuberc Respir Dis (Seoul) http://www.kidney.de/pget.php?&tw=1&pmid=26175768 #FOAvip Drug-resistant tuberculosis (TB) is still a major threat worldwide. However, recent scientific advances in diagnostic and therapeutic tools have improved the management of drug-resistant TB. The development of rapid molecular testing methods allows for the early detection of drug resistance and prompt initiation of an appropriate treatment. In addition, there has been growing supportive evidence for shorter treatment regimens in multidrug-resistant TB; and for the first time in over 50 years, new anti-TB drugs have been developed. The World Health Organization has recently revised their guidelines, primarily based on evidence from a meta-analysis of individual patient data (n=9,153) derived from 32 observational studies, and outlined the recommended combination and correct use of available anti-TB drugs. This review summarizes the updated guidelines with a focus on the medical management of drug-resistant TB. Twit Text FOAVip Medical Management of Drug-Resistant Tuberculosis ????Tuberc Respir Dis (Seoul) http://www.kidney.de/pget.php?&tw=1&pmid=26175768 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26175768 #FOAvip English Wikipedia <ref>{{Cite pmid|26175768}}</ref> Medical Management of Drug-Resistant Tuberculosis #MMPMID26175768 Jeon D Tuberc Respir Dis (Seoul) 2015[Jul]; 78 (3): 168-74 PMID26175768show ga Drug-resistant tuberculosis (TB) is still a major threat worldwide. However, recent scientific advances in diagnostic and therapeutic tools have improved the management of drug-resistant TB. The development of rapid molecular testing methods allows for the early detection of drug resistance and prompt initiation of an appropriate treatment. In addition, there has been growing supportive evidence for shorter treatment regimens in multidrug-resistant TB; and for the first time in over 50 years, new anti-TB drugs have been developed. The World Health Organization has recently revised their guidelines, primarily based on evidence from a meta-analysis of individual patient data (n=9,153) derived from 32 observational studies, and outlined the recommended combination and correct use of available anti-TB drugs. This review summarizes the updated guidelines with a focus on the medical management of drug-resistant TB. �Medical Management of Drug-Resistant Tuberculosis (epmc).pdf DeepDyve Pubget Overpricing